Molecular and Histopathologic Characteristics of Multifocal Papillary Thyroid Carcinoma

被引:3
|
作者
Bansal, Mona [1 ]
Gandhi, Manoj [1 ]
Ferris, Robert L. [2 ]
Nikiforova, Marina N. [1 ]
Yip, Linwah [3 ]
Carty, Sally E. [3 ]
Nikiforov, Yuri E. [1 ]
机构
[1] Univ Pittsburgh, Dept Pathol & Lab Med, Sch Med, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Dept Otolaryngol, Sch Med, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Div Endocrine Surg, Sch Med, Pittsburgh, PA 15213 USA
关键词
papillary thyroid carcinoma; multifocality; clonality; BRAF; NRAS; DISTINCT TUMOR FOCI; INDEPENDENT CLONAL ORIGIN; INTRAGLANDULAR DISSEMINATION; BRAF MUTATIONS; CANCER; REARRANGEMENTS;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Papillary thyroid carcinoma (PTC) is frequently multifocal, which can represent either intraglandular spread from a single primary tumor or multiple synchronous primary tumors (MSPTs). To distinguish and characterize these entities, we investigated whether multifocal PTCs contain genetically similar or different mutations and have particular histopathologic characteristics. In 60 cases of PTC with 2 to 4 discrete tumor foci, each focus was tested for BRAF, NRAS, HRAS, and KRAS point mutations and RET/PTC1 and RET/PTC3 rearrangements and analyzed for various histopathologic features. Overall, BRAF mutations were found in 43% of tumors, RAS in 27%, and RET/PTC in 2%. Four different patterns of mutation occurrence were identified: (i) 2 foci containing different mutations (30%); (ii) 1 tumor containing a mutation and another carrying no mutations (32%); (iii) both/all tumors containing the same mutation (25%); (iv) all tumors having no mutations (13%). The 30% of cases with 2 different mutations represent a group of tumors that are unequivocally MSPT. These tumors more commonly occurred in different lobes, although they could be located as close as 0.6 cm from each other. Moreover, MSPTs typically demonstrated distinct histologic variants/microscopic features, were encapsulated or had a smooth border, and showed no microscopic peritumoral dissemination. In conclusion, we demonstrate that at least 30% of multifocal PTCs represent unequivocal MSPTs that develop through distinct molecular alterations and that as many as 60% of multifocal PTCs are likely MSPTs. Histopathologically, MSPTs are typically located in different lobes, have distinct growth patterns, and do not show microscopic peritumoral dissemination.
引用
收藏
页码:1586 / 1591
页数:6
相关论文
共 50 条
  • [31] PREDICTORS OF MULTIFOCAL PAPILLARY THYROID CANCER. DO THEY EXIST?
    Mazur, O. V.
    Palamarchuk, V. A.
    Tovkai, O. A.
    Kuts, V. V.
    Shidlovskyi, V. O.
    Sheremet, M. I.
    Levchuk, R. D.
    Morozovych, I. I.
    Lazaruk, O. V.
    Cretoiu, D.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2022, 18 (04) : 424 - 428
  • [32] Genetic landscape of papillary thyroid carcinoma in the Chinese population
    Liang, Jialong
    Cai, Wanshi
    Feng, Dongdong
    Teng, Huajing
    Mao, Fengbiao
    Jiang, Yi
    Hu, Shanshan
    Li, Xianfeng
    Zhang, Yujie
    Liu, Baoguo
    Sun, Zhong Sheng
    JOURNAL OF PATHOLOGY, 2018, 244 (02) : 215 - 226
  • [33] Associations Between Metabolic Obesity Phenotypes and Pathological Characteristics of Papillary Thyroid Carcinoma
    Li, Xiuyun
    Zhang, Xiujuan
    Sun, Li
    Yang, Lulu
    Li, Qihang
    Wang, Zhixiang
    Wu, Yafei
    Gao, Ling
    Zhao, Jiajun
    Guo, Qingling
    Zhou, Meng
    ENDOCRINE PRACTICE, 2024, 30 (07) : 624 - 630
  • [34] A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma
    Chou, Angela
    Qiu, Min Ru
    Crayton, Henry
    Wang, Bin
    Ahadi, Mahsa S.
    Turchini, John
    Clarkson, Adele
    Sioson, Loretta
    Sheen, Amy
    Singh, Nisha
    Clifton-Bligh, Roderick J.
    Robinson, Bruce G.
    Gild, Matti L.
    Tsang, Venessa
    Leong, David
    Sidhu, Stanley B.
    Sywak, Mark
    Delbridge, Leigh
    Aniss, Ahmad
    Wright, Dale
    Graf, Nicole
    Kumar, Amit
    Rathi, Vivek
    Benitez-Aguirre, Paul
    Glover, Anthony R.
    Gill, Anthony J.
    MODERN PATHOLOGY, 2023, 36 (12)
  • [35] Multifocal papillary thyroid carcinoma—a consensus report of the European Society of Endocrine Surgeons (ESES)
    Maurizio Iacobone
    Svante Jansson
    Marcin Barczyński
    Peter Goretzki
    Langenbeck's Archives of Surgery, 2014, 399 : 141 - 154
  • [36] Analysis of BRAF Gene Mutation in Hashimoto's Thyroiditis With Multifocal Papillary Thyroid Carcinoma
    Wang, Feng
    Su, Yanling
    Yao, Xiyu
    Liu, Jie
    Ke, Qingxian
    AMERICAN SURGEON, 2025, 91 (02) : 186 - 190
  • [37] Papillary Thyroid Carcinoma in Children and Adolescents
    Chung, Bo Mi
    Park, Sung Hee
    Kim, Soo Jin
    Seo, Jae Seung
    Kim, Yang Soo
    Shim, Hyung Jin
    Lee, Jong Beum
    ULTRASOUND QUARTERLY, 2014, 30 (03) : 193 - 196
  • [38] Primary hyperparathyroidism and incidental multifocal metastatic papillary thyroid carcinoma in a man
    Polyzos, Stergios A.
    Anastasilakis, Athanasios D.
    Iakovou, Ioannis P.
    Partsalidou, Valassia
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (06) : 578 - 582
  • [39] Clinicopathologic characteristics and outcomes of papillary thyroid carcinoma in younger patients
    Lu, Yi
    Jiang, Lin
    Chen, Chao
    Chen, Haitao
    Yao, Qinghua
    MEDICINE, 2020, 99 (15) : E19795
  • [40] Hobnail Variant of Papillary Thyroid Carcinoma Clinicopathologic and Molecular Evidence of Progression to Undifferentiated Carcinoma in 2 Cases
    Cameselle-Teijeiro, Jose M.
    Rodriguez-Perez, Irene
    Celestino, Ricardo
    Eloy, Catarina
    Piso-Neira, Magali
    Abdulkader-Nallib, Ihab
    Soares, Paula
    Sobrinho-Simoes, Manuel
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (06) : 854 - 860